As a ubiquitin ligase subunit, SKP2 can target to degrade CDKN1B, promote the transformation of cells from the G1 phase to the S phase, and then cause the growth and proliferation of cancer cells; this is considered the typical function of SKP2 [46–48]. This evidence concerns the gene CDKN1B and cancer.